James Tour,Redwan Huq,Jason A. Mann,Almaz Jalilov,Lizanne Nilewski,Tom Kent,Christine Beeton
申请号：
US14978448
公开号：
US20160175292A1
申请日:
2015.12.22
申请国别(地区):
US
年份:
2016
代理人:
摘要：
Disclosed is a method of treating diseases which are: reactive oxygen species mediated, ischemic or reperfusion-related, or T-cell mediated, including autoimmune diseases. The method is administering a therapeutically effective amount of a formulation wherein the active ingredient includes non-phenolic aromatic structures that are electron deficient and are capable of converting the superoxide radical to O2 and/or of converting superoxide radical to oxygen and hydrogen peroxide, or pharmaceutically acceptable salts of said structures. Also disclosed is a method of diagnosing and treating such diseases and conditions.
